| Literature DB >> 28834048 |
David A Hill1,2, Allison Barz Leahy3, Joseph Sciasci4, Sean P O'Neill5, Anne Reilly3, Naomi Balamuth3, Steven H Seeholzer6, Jonathan M Spergel1,2, Terri F Brown-Whitehorn1.
Abstract
Vincristine (VCR) is a vinca alkaloid and common chemotherapeutic that is used to treat multiple pediatric and adult malignancies. Despite its common use, cases of anaphylaxis to VCR are rare and typically isolated to a single individual. We report a series of eight patients with adverse reactions to VCR over the course of 11 months at a single institution, four of which progressed to anaphylaxis and one of which resulted in cardiac arrest. Mass spectrometry analysis of medication lots was performed to test for possible contaminant(s). Our findings highlight the risk of anaphylaxis during therapy with VCR.Entities:
Keywords: allergy; anaphylaxis; contaminant; mass spectrometry; vincristine
Mesh:
Substances:
Year: 2017 PMID: 28834048 PMCID: PMC5978699 DOI: 10.1002/pbc.26761
Source DB: PubMed Journal: Pediatr Blood Cancer ISSN: 1545-5009 Impact factor: 3.167